Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
April 3, 2015

Recent Stories of Interest

From Drug Benefit News - In a move that surprised many industry analysts, UnitedHealth Group on March 30 unveiled plans to acquire stand-alone PBM Catamaran Corp. and merge it with the health plan operator’s PBM unit, OptumRx. The combined firm will process approximately 1 billion prescriptions per year, securing OptumRx’s spot as the third-largest PBM. Under the agreement, UnitedHealth Group will acquire Catamaran’s outstanding common stock for $61.50 per share in cash. Read more

Although the Alzheimer’s disease drug pipeline has been plagued by failures and… Read more

Amid rising drug costs due to a multitude of factors (see story,… Read more

Building on an ongoing effort to improve medication use in certain patient… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

April 16, 2015
FDA Approves First Generic Copaxone for MS

The FDA approved Sandoz’s Glatopa, the first generic version of Teva’s multiple sclerosis treatment Copaxone (glatiramer acetate) in a 20 mg/ml once-daily injection

April 15, 2015
HHS Will Investigate Generic Drug Inflation

The Office of the Inspector General plans to investigate recent price increases for generic drugs paid through Medicaid.

March 20, 2015
Judge Clears Way for First Biosimilar Launch

Judge declines to grant Amgen’s request for injunction to prevent Sandoz biosimilar Zarxio from launching; reference drug is Amgen’s Neupogen

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?